Does Wegovy Affect Potassium Levels?

What the STEP 1 trial data tell us about electrolytes

The STEP 1 trial (a 68-week study in adults with obesity, published in the New England Journal of Medicine) tested semaglutide 2.4mg against placebo in over 1,900 participants and remains the foundational evidence base for Wegovy's weight-management licence. Serum potassium was not flagged as a clinically significant finding. That is broadly consistent with how GLP-1 receptor agonists work: they act on appetite centres and the gut, not on the kidneys' handling of electrolytes in the way that, say, a diuretic does.

There is a common assumption that any medicine affecting the gut must be scrambling your mineral levels in dramatic ways. The reality is more mundane. For the majority of people on Wegovy, potassium sits within normal range throughout treatment. The risk picture shifts when GI side effects are severe enough to cause meaningful fluid loss, something the trial data show is uncommon but not impossible, particularly around dose increases. You can read more about how semaglutide behaves in the body on our semaglutide overview page.

The NHS medicines page for semaglutide lists the recognised side effects plainly: nausea, vomiting, diarrhoea and constipation are the most common, particularly when starting or moving up a dose. These are the indirect pathways through which potassium could theoretically fall, not a direct pharmacological action of the drug.

When GI side effects become the real concern

Potassium is lost through vomiting and diarrhoea. That is basic physiology. If someone is vomiting repeatedly after a dose increase and eating or drinking very little for several days, electrolyte levels (potassium among them) can drop. This is why dehydration from persistent GI illness is listed as a reason to seek medical attention, not something to ride out quietly at home.

Signs that warrant a call to your GP or pharmacist include dizziness, muscle weakness, cramps, or palpitations alongside prolonged vomiting or diarrhoea. These could reflect electrolyte imbalance, dehydration, or both. On the Wegovy treatment page we cover the full side-effect picture in context, including when GI symptoms are expected to settle and when they need clinical attention.

For people whose kidneys already have reduced function, potassium management matters more, the kidneys regulate how much potassium the body retains, so anything that stresses them through dehydration adds a layer of risk. Prescribers at a service like ours review medical history carefully before approving treatment, precisely because these interactions are not always obvious to patients.

Groups where the potassium question deserves closer prescriber scrutiny

Most adults starting Wegovy at standard eligibility thresholds (BMI of 30 or above, or 27-plus with a relevant weight-related condition) will not have a potassium issue to manage. But a subset of people have pre-existing reasons to be more careful. ACE inhibitors and angiotensin-receptor blockers, both commonly prescribed for high blood pressure, can raise potassium. Certain diuretics (loop diuretics in particular) lower it. If someone is on a complex antihypertensive regimen and then starts Wegovy, monitoring blood chemistry at the outset is reasonable clinical practice.

People with type 2 diabetes who are also managing kidney complications sit in a similar category. Wegovy's interaction with blood sugar regulation is a related topic worth reading alongside this one if that applies to you. Your prescriber can consider whether baseline bloods or follow-up testing makes sense for your individual situation. The consultation is also the right moment to mention any supplement you take, since high-dose potassium supplementation alongside medicines that raise potassium can occasionally overshoot.

A question our prescribers hear regularly is whether Wegovy also changes hormone levels or other markers, the short answer is that it primarily acts on appetite and metabolism, though there are specific questions worth reading about, such as whether Wegovy affects oestrogen or how the Wegovy dosing schedule works in practice. Each of those has its own evidence picture.

Practical steps if you are already on Wegovy and concerned

If you are currently on Wegovy and noticing symptoms that might suggest low potassium (muscle cramps, unusual fatigue, heart flutters) do not wait. Contact your prescriber or GP. A simple blood test will give a clear answer. Eating potassium-rich foods (bananas, spinach, potatoes, white beans) is a sensible general habit during treatment, though dietary changes are not a substitute for medical assessment if symptoms are present.

If GI side effects are the reason you are worried, the usual pattern is that nausea and vomiting are worst in the first couple of weeks after starting or after a dose step up, then ease considerably. Keeping well hydrated during that window matters. Some people find that certain foods or the timing of their injection affects how they feel; altered taste perception during treatment is something patients occasionally raise, and there is a separate page exploring how Wegovy can affect taste if that is part of your experience.

If you are still in the process of deciding whether Wegovy is right for you, a prescriber can go through your full health picture (including any medicines that affect electrolytes) before you start. Check your eligibility through a free consultation and put your questions directly to a GPhC-registered prescriber who will review your case the same day.